Financials
- Market Capitalization 47.08 M
- Employee 58
- Founded 2005
- CEO N/A
- Website www.atyrpharma.com
- Headquarter Delaware, United States
- FIGI BBG001J2P692
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.95
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4237 | MCRB Seres Therapeutics, Inc. - Common Stock | 5.18 USD | +5.50% | +5.07% | +5.71% | -37.06% | 51.50 M USD | ||
| 4260 | HYPD Hyperion DeFi, Inc. - Common Stock | 3.09 USD | -9.65% | -7.49% | +17.49% | -47.89% | 48.02 M USD | ||
| 4273 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 7.17 USD | +2.72% | +5.60% | -0.83% | +714.77% | 46.69 M USD | ||
| 4274 | HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.96 USD | +2.13% | +6.67% | +166.67% | -26.15% | 46.66 M USD |